NO20052083L - Treatment of allergic conditions using IL-21 - Google Patents
Treatment of allergic conditions using IL-21Info
- Publication number
- NO20052083L NO20052083L NO20052083A NO20052083A NO20052083L NO 20052083 L NO20052083 L NO 20052083L NO 20052083 A NO20052083 A NO 20052083A NO 20052083 A NO20052083 A NO 20052083A NO 20052083 L NO20052083 L NO 20052083L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- allergic conditions
- allergic
- conditions
- diseases
- Prior art date
Links
- 206010027654 Allergic conditions Diseases 0.000 title abstract 2
- 241000132023 Bellis perennis Species 0.000 abstract 1
- 235000005633 Chrysanthemum balsamita Nutrition 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 208000030852 Parasitic disease Diseases 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 210000003979 eosinophil Anatomy 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Oppfinnelsen vedrører administieringen av IL-21 for håndtering, behandling og forebygging av sykdommer eller tilstander der eosinofiler er involvert i en beskyttende respons, f eks. allergiske reaksjoner, allergiske sykdommer, allergiske tilstander og parasittsykdonmier.The invention relates to the administration of IL-21 for the management, treatment and prevention of diseases or conditions in which eosinophils are involved in a protective response, e.g. allergic reactions, allergic diseases, allergic conditions and parasitic disease daisies.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200201587 | 2002-10-16 | ||
| PCT/DK2003/000691 WO2004032953A1 (en) | 2002-10-11 | 2003-10-13 | Treatment of allergic conditions by use of il 21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20052083L true NO20052083L (en) | 2005-04-28 |
Family
ID=35276285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052083A NO20052083L (en) | 2002-10-16 | 2005-04-28 | Treatment of allergic conditions using IL-21 |
Country Status (1)
| Country | Link |
|---|---|
| NO (1) | NO20052083L (en) |
-
2005
- 2005-04-28 NO NO20052083A patent/NO20052083L/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0518249A2 (en) | strain tolerant cotton plants | |
| NO20072352L (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
| NO20053077D0 (en) | Therapeutic formulations for the treatment of beta-amyloid-related diseases. | |
| TW200612926A (en) | Compounds and compositions as ppar modulators | |
| GB0222495D0 (en) | Compounds | |
| NO20055731L (en) | Cannabinoid receptor ligands and their use | |
| GT200500359A (en) | ORGANIC COMPOUNDS | |
| NO20073574L (en) | Triazole-substituted aminobenzophenone compounds | |
| UA83194C2 (en) | Pyrimidine derivatives and their use as cb2 modulators | |
| ATE517872T1 (en) | FIVE-MEMBER HETEROCYCLE-BASED P38 KINASE INHIBITORS | |
| BRPI0607897A2 (en) | oxindole compounds and their use as therapeutic agents | |
| NO20055894L (en) | Methods and compositions for the treatment of amyloid-related diseases | |
| PL2530083T3 (en) | BRUTON tyrosine kinase INHIBITORS | |
| WO2008076754A3 (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
| DK1809280T3 (en) | Mitotic kinesin inhibitors and methods for their use | |
| PA8657201A1 (en) | COMPOUNDS OF 3H-OXAZOLO AND 3H-TIAZOLO [4, 5-D] PIRIMIDIN-2-ONA 3, 5-DISUSTITUED AND 3, 5, 7 - TRISUSTITUIDA AND PROFARMACOS OF THE SAME | |
| GT200300294A (en) | INDAZOL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT PROTEINKINES AND PROCEDURES FOR USE | |
| DK1594833T3 (en) | 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases | |
| MX2007009356A (en) | Compounds and compositions as ppar modulators. | |
| EP1819227A4 (en) | PHARMACEUTICAL FORMULATION OF DECITABINE | |
| NO20052028L (en) | Pyridine derivatives as CB2 receptor modulators | |
| TW200602330A (en) | Compounds and compositions as PPAR modulators | |
| BRPI0512352A (en) | 3-aminocyclopentanecarboxamides as chemokine receptor modulators | |
| NO20055941L (en) | Use of a composition comprising a PDE4 inhibitor and a PDE5 inhibitor | |
| TW200611695A (en) | Pyrrolopyridine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |